Cost-effectiveness of colorectal screening in Portugal : was biennial FIT a good choice?

Detalhes bibliográficos
Autor(a) principal: Lopes, Luís Miguel da Silva Araújo
Data de Publicação: 2021
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.14/37064
Resumo: Economic evaluation is increasingly used by various health care systems to support decisions about which health technologies to fund with the limited resources available The design and implementation of the Portuguese colorectal cancer (CCR) screening program, using biennial fecal immunochemical test (FIT 2/2y) was not supported by any published cost-effective analysis using country specific data from a payer´s perspective. We aim to estimate the most cost-effective strategy for CCR screening in Portugal. A Markov model was developed to simulate the natural history of colorectal cancer and to estimate the cost effectiveness of five strategies for CRC screening, as well as no screening, in 50- year-old individuals at average risk for colorectal cancer. The primary outcome was the incremental cost-effectiveness ratio (ICER) between the different screening strategies. Colonoscopy 3/10 years is the most cost-effective strategy for colorectal screening in Portugal, with a cost-effectiveness ratio (ICER) of 802,07€ per QALY compared with colonoscopy every 10 years. The stool based strategies and CT colonography strategies are more expensive and less effective than colonoscopy based strategies for CCR screening. FIT 2/2 y showed the smallest gains in life years gained (LYG) (498.3 days) of all strategies, as well as the smallest reduction in the incidence of CRC (-37%) and the smallest reduction in CCR mortality (- 57%) under real-world adherence assumptions. According to our results, biennial FIT, the screening strategy used in Portugal, should be abandoned as it is the most expensive and less effective strategy for the NHS, and replaced by one of the two colonoscopy strategies.
id RCAP_7b3c0900f9c695fbc77f3c9d6b8dba9f
oai_identifier_str oai:repositorio.ucp.pt:10400.14/37064
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Cost-effectiveness of colorectal screening in Portugal : was biennial FIT a good choice?Cost-effectivenessICERScreeningColorectal cancerEconomic modellingCusto-eficáciaRastreioCancro colo rectalAvaliação económica em saúdeDomínio/Área Científica::Ciências Sociais::Economia e GestãoEconomic evaluation is increasingly used by various health care systems to support decisions about which health technologies to fund with the limited resources available The design and implementation of the Portuguese colorectal cancer (CCR) screening program, using biennial fecal immunochemical test (FIT 2/2y) was not supported by any published cost-effective analysis using country specific data from a payer´s perspective. We aim to estimate the most cost-effective strategy for CCR screening in Portugal. A Markov model was developed to simulate the natural history of colorectal cancer and to estimate the cost effectiveness of five strategies for CRC screening, as well as no screening, in 50- year-old individuals at average risk for colorectal cancer. The primary outcome was the incremental cost-effectiveness ratio (ICER) between the different screening strategies. Colonoscopy 3/10 years is the most cost-effective strategy for colorectal screening in Portugal, with a cost-effectiveness ratio (ICER) of 802,07€ per QALY compared with colonoscopy every 10 years. The stool based strategies and CT colonography strategies are more expensive and less effective than colonoscopy based strategies for CCR screening. FIT 2/2 y showed the smallest gains in life years gained (LYG) (498.3 days) of all strategies, as well as the smallest reduction in the incidence of CRC (-37%) and the smallest reduction in CCR mortality (- 57%) under real-world adherence assumptions. According to our results, biennial FIT, the screening strategy used in Portugal, should be abandoned as it is the most expensive and less effective strategy for the NHS, and replaced by one of the two colonoscopy strategies.A avaliação económica é cada vez mais utilizada pelos vários sistemas de saúde para apoiar decisões sobre quais as tecnologias de saúde a financiar com os recursos limitados disponíveis. O desenho e implementação do programa de rastreio do cancro colo-rectal (CCR) em Portugal, utilizando como teste de rastreio, o teste imunoquímico fecal (FIT) bianual não foi suportado por nenhum estudo custo-eficácia conhecido, na perspetiva do Serviço Nacional de Saúde (SNS), usando dados específicos do país. Neste trabalho pretendemos determinar a estratégia mais custo-eficaz para o rastreio do CCR em Portugal. Foi desenvolvido um modelo de Markov para simular a história natural do CCR e avaliar a relação custo-eficácia de cinco estratégias de rastreio, bem como do não rastreio, em indivíduos com 50 anos de idade com risco médio de CCR. O outcome primário é a razão de custo-efetividade incremental (ICER) entre as diferentes estratégias de rastreio. A colonoscopia 3/10 anos é a estratégia mais custo-eficaz para o rastreio do CCR em Portugal, com um ICER de 802,07€ por QALY em comparação com a colonoscopia a cada 10 anos. As estratégias baseadas em testes de sangue oculto nas fezes e a colonografia por TC são mais caras e menos eficazes do que as estratégias baseadas em colonoscopia para o rastreio do CCR. A FIT bianual é a estratégia com os menos anos de vida ganhos (LYG) (498.3 dias) de todas as estratégias, bem como a que apresenta menor diminuição da incidência de CRC (-37%) e a menor redução na mortalidade por CCR (-57 %) num cenário de aderência realista. De acordo com os nossos resultados, a FIT bianual, a estratégia de rastreio utilizada em Portugal, deve ser abandonada por ser a estratégia mais cara e vi menos eficaz para o SNS, e substituída por uma das duas estratégias baseadas na colonoscopia.Gonçalves, Ricardo Landeiro de SousaVeritati - Repositório Institucional da Universidade Católica PortuguesaLopes, Luís Miguel da Silva Araújo2023-03-17T01:30:29Z2022-01-212021-092022-01-21T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10400.14/37064TID:202962172enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-12T17:42:30Zoai:repositorio.ucp.pt:10400.14/37064Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:30:08.157158Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Cost-effectiveness of colorectal screening in Portugal : was biennial FIT a good choice?
title Cost-effectiveness of colorectal screening in Portugal : was biennial FIT a good choice?
spellingShingle Cost-effectiveness of colorectal screening in Portugal : was biennial FIT a good choice?
Lopes, Luís Miguel da Silva Araújo
Cost-effectiveness
ICER
Screening
Colorectal cancer
Economic modelling
Custo-eficácia
Rastreio
Cancro colo rectal
Avaliação económica em saúde
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
title_short Cost-effectiveness of colorectal screening in Portugal : was biennial FIT a good choice?
title_full Cost-effectiveness of colorectal screening in Portugal : was biennial FIT a good choice?
title_fullStr Cost-effectiveness of colorectal screening in Portugal : was biennial FIT a good choice?
title_full_unstemmed Cost-effectiveness of colorectal screening in Portugal : was biennial FIT a good choice?
title_sort Cost-effectiveness of colorectal screening in Portugal : was biennial FIT a good choice?
author Lopes, Luís Miguel da Silva Araújo
author_facet Lopes, Luís Miguel da Silva Araújo
author_role author
dc.contributor.none.fl_str_mv Gonçalves, Ricardo Landeiro de Sousa
Veritati - Repositório Institucional da Universidade Católica Portuguesa
dc.contributor.author.fl_str_mv Lopes, Luís Miguel da Silva Araújo
dc.subject.por.fl_str_mv Cost-effectiveness
ICER
Screening
Colorectal cancer
Economic modelling
Custo-eficácia
Rastreio
Cancro colo rectal
Avaliação económica em saúde
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
topic Cost-effectiveness
ICER
Screening
Colorectal cancer
Economic modelling
Custo-eficácia
Rastreio
Cancro colo rectal
Avaliação económica em saúde
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
description Economic evaluation is increasingly used by various health care systems to support decisions about which health technologies to fund with the limited resources available The design and implementation of the Portuguese colorectal cancer (CCR) screening program, using biennial fecal immunochemical test (FIT 2/2y) was not supported by any published cost-effective analysis using country specific data from a payer´s perspective. We aim to estimate the most cost-effective strategy for CCR screening in Portugal. A Markov model was developed to simulate the natural history of colorectal cancer and to estimate the cost effectiveness of five strategies for CRC screening, as well as no screening, in 50- year-old individuals at average risk for colorectal cancer. The primary outcome was the incremental cost-effectiveness ratio (ICER) between the different screening strategies. Colonoscopy 3/10 years is the most cost-effective strategy for colorectal screening in Portugal, with a cost-effectiveness ratio (ICER) of 802,07€ per QALY compared with colonoscopy every 10 years. The stool based strategies and CT colonography strategies are more expensive and less effective than colonoscopy based strategies for CCR screening. FIT 2/2 y showed the smallest gains in life years gained (LYG) (498.3 days) of all strategies, as well as the smallest reduction in the incidence of CRC (-37%) and the smallest reduction in CCR mortality (- 57%) under real-world adherence assumptions. According to our results, biennial FIT, the screening strategy used in Portugal, should be abandoned as it is the most expensive and less effective strategy for the NHS, and replaced by one of the two colonoscopy strategies.
publishDate 2021
dc.date.none.fl_str_mv 2021-09
2022-01-21
2022-01-21T00:00:00Z
2023-03-17T01:30:29Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.14/37064
TID:202962172
url http://hdl.handle.net/10400.14/37064
identifier_str_mv TID:202962172
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132022719905792